Market Value295,642,000
Total Holdings79
File Date2022-10-28
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
COGT / Cogent Biosciences, Inc.
BCAB / BioAtla, Inc.
CFRX / ContraFect Corp Put
STXS / Stereotaxis, Inc.
ELOX / Eloxx Pharmaceuticals, Inc.
VERU / Veru Inc. Put
VRAYQ / ViewRay, Inc.
IMTX / Immatics N.V.
CDXS / Codexis, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ALT / Altimmune, Inc.
PHR / Phreesia, Inc.
HZNP / Horizon Therapeutics Plc
RLMD / Relmada Therapeutics, Inc. Put
BCRX / BioCryst Pharmaceuticals, Inc.
ESPR / Esperion Therapeutics, Inc.
ARVN / Arvinas, Inc.
CCXI / ChemoCentryx Inc
MCRB / Seres Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
XENE / Xenon Pharmaceuticals Inc.
SGEN / Seagen Inc
CGEN / Compugen Ltd.
MGTX / MeiraGTx Holdings plc
LVTX / LAVA Therapeutics N.V.
IMVT / Immunovant, Inc.
IMGN / ImmunoGen, Inc.
RXDX / Prometheus Biosciences Inc Put
HGEN / Humanigen, Inc. Put
ZYME / Zymeworks Inc.
OTIC / Otonomy Inc
DAWN / Day One Biopharmaceuticals, Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
SBTX / Silverback Therapeutics Inc
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
KYG5960S1241 / Medicus Sciences Acquisition Corp.
ABOS / Acumen Pharmaceuticals, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
NCNA / NuCana plc - Depositary Receipt (Common Stock)
VCYT / Veracyte, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
AKRO / Akero Therapeutics, Inc.
FMTX / Forma Therapeutics Holdings Inc
CGEM / Cullinan Therapeutics, Inc.
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
CLDX / Celldex Therapeutics, Inc. Put
BIIB / Biogen Inc.
VRTX / Vertex Pharmaceuticals Incorporated
CTIC / CTI BioPharma Corp
ALNY / Alnylam Pharmaceuticals, Inc. Call
ISEE / IVERIC bio Inc Put
PYPD / PolyPid Ltd.
APEN / Apollo Endosurgery Inc
PRTA / Prothena Corporation plc Put
MRTX / Mirati Therapeutics, Inc. Call
CMPX / Compass Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
KRTX / Karuna Therapeutics, Inc.
RGNX / REGENXBIO Inc.
PYPD / PolyPid Ltd. Put
AVXL / Anavex Life Sciences Corp. Call
AVXL / Anavex Life Sciences Corp. Put
NKTX / Nkarta, Inc.
BHVN / Biohaven Ltd.
CLNN / Clene Inc. Put
ALLK / Allakos Inc.
CVRX / CVRx, Inc.
ISEE / IVERIC bio Inc
EYPT / EyePoint Pharmaceuticals, Inc.
PSTX / Poseida Therapeutics, Inc.
PNT / POINT Biopharma Global Inc.
MRTX / Mirati Therapeutics, Inc.
UTHR / United Therapeutics Corporation
NGM / NGM Biopharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
BLU / Bellus Health Inc
PLRX / Pliant Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
NTLA / Intellia Therapeutics, Inc.
PRTA / Prothena Corporation plc
ITCI / Intra-Cellular Therapies, Inc.
TERN / Terns Pharmaceuticals, Inc.
KRYS / Krystal Biotech, Inc.
ALGS / Aligos Therapeutics, Inc.
TRVI / Trevi Therapeutics, Inc.
MORF / Morphic Holding, Inc.
EVGN / Evogene Ltd.
CLDX / Celldex Therapeutics, Inc.
MRUS / Merus N.V.
NUVL / Nuvalent, Inc.
ETNB / 89bio, Inc.
MGNX / MacroGenics, Inc.
CERS / Cerus Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
MRSN / Mersana Therapeutics, Inc.
ELYM / Eliem Therapeutics, Inc.